NCT04671472View on ClinicalTrials.gov

Efficacy Confirmation Study of NPC-09

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

March 29, 2022

Study Completion Date

March 29, 2022

Conditions
GNE MyopathyDistal Myopathy With Rimmed Vacuoles (DMRV)Hereditary Inclusion Body Myopathy (hIBM)Nonaka Disease
Interventions
DRUG

NPC-09

The drug will be administered by the oral route with the same manner

DRUG

NPC-09 placebo

The drug will be administered by the oral route with the same manner

Trial Locations (5)

Unknown

Nagoya University Hospital, Nagoya

Tohoku University Hospital, Sendai

Osaka University Hospital, Suita

National Center Hospital of Neurology and Psychiatry Hospita, Kodaira

Kumamoto University Hospital, Kumamoto

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT04671472 - Efficacy Confirmation Study of NPC-09 | Biotech Hunter | Biotech Hunter